These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2690608)

  • 1. Human insulin: DNA technology's first drug.
    The MJ
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S9-11. PubMed ID: 2690608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
    Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
    J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of recombinant human insulin.
    Frank BH
    Dev Biol Stand; 1998; 96():91-5. PubMed ID: 9890521
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
    Shin CS; Hong MS; Bae CS; Lee J
    Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered insulin: five years of experience.
    Brogard JM; Blickle JF; Paris-Bockel D
    Drugs Exp Clin Res; 1985; 11(6):397-406. PubMed ID: 3915289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human insulin.
    Ladisch MR; Kohlmann KL
    Biotechnol Prog; 1992; 8(6):469-78. PubMed ID: 1369033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on somatic gene therapy for diabetes. I. Structuring of recombinant from human insulin gene and ammalian expression vector PRC/CMV].
    Xiao X; Wang H; Fang F; Sun Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):145-9. PubMed ID: 10453511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of human insulin gene expression recombinant and its effect on blood glucose of diabetic rats.
    Wang H; Xiao X; Fang F; Sun Q
    Chin Med J (Engl); 1998 Oct; 111(10):899-902. PubMed ID: 11189235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic engineering of human insulin. II. Exclusion HPLC of biotechnological precursors. Factors affecting resolution and selectivity].
    Kliushnichenko VE; Vul'son AN
    Bioorg Khim; 1993 Feb; 19(2):174-81. PubMed ID: 8498958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of recombinant human insulin--study of downstream process].
    Yu R; Li X; Yang J; Wu W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):805-8. PubMed ID: 15553863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of deleting A19 tyrosine from insulin.
    Du X; Tang JG
    Biochem Mol Biol Int; 1998 Mar; 44(3):507-13. PubMed ID: 9556211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated insulin gene transfer improves nutritional and post-hepatectomized conditions in diabetic rats.
    Yamaguchi M; Kuzume M; Matsumoto T; Shimura H; Matsumiya A; Nakano H; Takeda M; Sanada Y; Kumada K
    Surgery; 2000 Jun; 127(6):670-8. PubMed ID: 10840363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
    Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
    Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin antibodies in the maternal and foetal circulation of pregnant diabetic women treated with human insulin of recombinant DNA origin.
    Leiper JM; Fineberg SE; Lunan CB; MacCuish AC
    Diabetes Res; 1984 Jul; 1(2):75-81. PubMed ID: 6397289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P; Rivereau AS
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin formulations--a review.
    Gualandi-Signorini AM; Giorgi G
    Eur Rev Med Pharmacol Sci; 2001; 5(3):73-83. PubMed ID: 12004916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-C-peptide human proinsulin.
    Wei G; Hu MH; Tang JG
    Biochem Mol Biol Int; 1995 Jan; 35(1):37-46. PubMed ID: 7735138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.